nab-sirolimus Clinical Trials
3 recruitingDrug
Phase 22Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 1
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
Advanced Solid TumorTumorTumor, Solid
Aadi Bioscience, Inc.28 enrolled2 locationsNCT05661461
Recruiting
Phase 2
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Endometrial CancerCancerTumor+3 more
Aadi Bioscience, Inc.29 enrolled9 locationsNCT05997017
Recruiting
Phase 2
Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors
Neuroendocrine TumorsPancreatic Neuroendocrine TumorGastrointestinal Neuroendocrine Tumor+2 more
Aadi Bioscience, Inc.21 enrolled4 locationsNCT05997056